North Shore University Hospital Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2009
NCT00822094
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

North Shore University Hospital | North Shore University Hospital, 300 Community Drive, Manhasset, NY 11030

Active Ingredients

Drugs in Phase 3 Trials (1)

zirconium silicate (Lokelma) (1 trial)

Drugs in Phase 2 Trials (3)

cytarabine (cytosar-u) (1 trial)

daunorubicin (cerubidine) (1 trial)

iron oxide (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia (Phase 2)

Anemia, Iron-Deficiency (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 4